Delivery Order SPE2DR25D1034-SPE2DR26FPW2S
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded a $7,213.21 delivery order contract to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 12, 2025, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $34,247.33 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a direct fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $6,125.90 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets, with performance in Conshohocken, Pennsylvania and completion targeted for December 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.29 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 24, 2025, with completion expected by November 25, 2025. This is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,074.40 for 30 tablets of Arimidex 1 mg, with performance in Conshohocken, Pennsylvania. This competitive, non-set-aside contract reflects firm fixed pricing and is scheduled for completion on November 13, 2025. The award represents a single delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,392.18 by the Defense Logistics Agency (DLA) on December 15, 2025, for the supply of Arimidex 1 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of December 16, 2025, and performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a standard pharmaceutical procurement supporting federal medical supply requirements,...
- The Defense Logistics Agency awarded a $3,407.96 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed price contract, issued without set-aside designation, represents a competitively awarded order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPW2SDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,726.80 to supply Arimidex 1 mg tablets in a 30-count package. The order, issued on December 5, 2025, with completion by December 8, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This contract was awarded without set-aside provisions through open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive $999,999,999.00 prime IDC with DLA Troop Support Medical (contract SPE2DX), valid through December 2026. This umbrella contract enables the company to deliver a broad range of pharmaceutical products, medical supplies, brand-name and generic medications, and specialized healthcare commodities to support Defense Health Agency and other government healthcare programs globally. AmerisourceBergen's federal contract performance demonstrates its capability to fulfill diverse medical supply requirements through competitive procurements, positioning the company as a key supplier within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 12/4/25 |